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Improved methods for manipulating and analyzing
gene function have provided a better understanding
of how genes work during organ development and
disease. Inducible functional genetic mosaics can
be extraordinarily useful in the study of biological
systems; however, this experimental approach is
still rarely used in vertebrates. This is mainly due to
technical difficulties in the assembly of large DNA
constructs carrying multiple genes and regulatory
elements and their targeting to the genome. In addi-
tion, mosaic phenotypic analysis, unlike classical
single gene-function analysis, requires clear labeling
and detection of multiple cell clones in the same tis-
sue. Here, we describe several methods for the rapid
generation of transgenic or gene-targeted mice and
embryonic stem (ES) cell lines containing all the
necessary elements for inducible, fluorescent, and
functional genetic mosaic (ifgMosaic) analysis. This
technology enables the interrogation of multiple
and combinatorial gene function with high temporal
and cellular resolution.
INTRODUCTION
The ability to modify gene function at very high temporal and
spatial resolution has radically altered the study of biologically
and biomedically relevant processes. Genetic mosaics are a
particularly powerful research tool because they allow the study
of cell-autonomous effects when distinct mutant and wild-type
cells confront the same environment in the same tissue or organ-
ism. The analysis of genetic mosaics allows single-cell, or clonal
phenotypic analysis, where the only difference between the cells
used for comparative analysis is the induced mutation or the
expression of a given gene in an otherwise identical organism800 Cell 170, 800–814, August 10, 2017 ª 2017 The Authors. Publish
This is an open access article under the CC BY license (http://creativeand genetic background. This approach is often more precise
and informative than the use of classical genetics, in which the
comparison is made between distinct wild-type and mutant an-
imals that may develop secondary and non-cell-autonomous
phenotypes over time, distorting interpretation of the process
under study. Genetic mosaics have been used extensively in
the fruit fly due to the ease of performing mitotic recombination
and have revolutionized the study of cell biology in this model or-
ganism. However, it is technically more challenging to induce
and analyze genetic mosaics in the mouse, the most widely
used model organism in biomedical research. One of the
methods used to induce mitotic genetic mosaics in mice is
MADM (mosaic analysis with double markers), which allows
the labeling of control and mutant cells with different markers
(Zong et al., 2005). However, thismethod relies on very rare inter-
chromosomal recombination events, leading to the generation of
only a few clones of labeled control andmutant cells in the tissue.
The generation of these genetic mosaics also cannot be accu-
rately controlled in time, since these rare events can only occur
with constitutively active Cre lines and not tamoxifen-inducible
CreERT2 lines, which are weaker and only transiently active.
In addition, the requirement for genetic linkage between the en-
gineered MADM elements and another gene mutation means
that currently this method can only be performed with genes
located on 4 of the 20 mouse chromosomes (Zong, 2014). A
more widely used method to generate functional genetic mo-
saics in the mouse involves partial or mosaic induction of Cre-
LoxP intrachromosomal recombination, resulting in deletion of
floxed genes. With this method, the location, timing, and fre-
quency of the recombination events can be regulated by restrict-
ing the expression of CreERT2 to a given tissue and by varying
the timing and dosage of the CreERT2 ligand tamoxifen. Mosaic
induction of floxed-alleles recombination is frequently associ-
ated with the use of independent, and genetically distinct, fluo-
rescent reporters of recombination, or Cre activity (Srinivas
et al., 2001). However, several studies have shown that these
cannot be used to reliably report another given gene deletion
or activation (Liu et al., 2013; Long and Rossi, 2009; Vooijsed by Elsevier Inc.
commons.org/licenses/by/4.0/).
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et al., 2001). This lack of correlation between recombination of a
reporter allele, and alteration of the gene of interest, means that
the majority of current conditional and mosaic genetic modifica-
tions and function analysis in themouse are conducted without a
reliable readout. This technical problem can be circumvented by
immunostaining for the protein encoded by the deleted or acti-
vated gene, to ensure that it is either absent or upregulated in
the desired cells. However, for most proteins, the immunostain-
ing signal is too weak or does not provide sufficient cellular res-
olution to clearly identify the cell shape and thus permit quantifi-
cation of the phenotype of cells with a given genetic alteration.
Moreover, immunostaining requires fixed cells and is thus
incompatible with direct live imaging of the mutant or recom-
bined cells.
With this in mind, we have developed and tested new strate-
gies for the conditional induction of mosaic gene expression
linked to the expression of different and compatible fluorescent
marker proteins. The methods described here use an open-
source DNA engineering strategy that greatly simplifies the pro-
duction of large and complex constructs for inducible, fluores-
cent, and genetic mosaic (ifgMosaic) studies. We also provide
an easy-to-follow pipeline for mouse Rosa26 BAC recombineer-
ing and transgenesis that enables robust and rapid generation of
ifgMosaic mice and a method for CRISPR/Cas9-induced gene
targeting of large mosaic constructs in the Rosa26 locus of
mouse embryonic stem (ES) cells. This methodology will greatly
simplify combinatorial mosaic gene-function analysis with high
genetic and cellular resolution.
RESULTS
Dual ifgMosaic Strategy for High-Resolution Mosaic
Analysis of Gene Function
One of the difficulties limiting our understanding of biological
processes is our inability to clearly distinguish phenotypes at
the single-cell level. Most tissues are composed of groups of
tightly packed and adhered cells. Classical mouse genetics
and standard antibody immunostaining provide tissue resolution
but not single-cell resolution (Figure 1A). Standard unicolor or
single-molecule reporters, which label a given cell or tissue
with a single protein localized in the cytoplasm, membrane, or
nucleus, do not allow the simultaneous and accurate determina-
tion of clone-cell shape and number, thus limiting our under-
standing of the clonal phenotype and its tissue distribution (Fig-
ures 1B and 1C). We therefore assembled several distinct DNAFigure 1. Inducible Dual Membrane and Chromatin Mosaic Constructs
(A) Endothelial surface (IsolectinB4) and DNA (Hoechst) markers allow the visual
(B–D) The cell membrane (B) or nuclei (C) can be visualized with Mb or H2B-tagg
shape and number.
(E and F) In iMb-Mosaic and iChr-Mosaic constructs andmouse lines, recombinati
mediated recombination generates three possible outcomes for each construct (A
the DNA elements description.
(G) When onemouse or cell line contains the two inducible mosaic alleles (iMb-Mo
tissue, allowing combinatorial epistasis analysis at single-cell resolution. A–F ind
(H) Dual ifgMosaic in ES cells and live imaging of their distinct fluorescent signal
(I and J) Retina vasculature of a growing newborn mouse containing the iMb-M
of recombination with tamoxifen. The genetic mosaic is detected within the I
immunostaining signals. Single- and dual-labeled clones are visible at low (I) and
802 Cell 170, 800–814, August 10, 2017constructs that allow conditional and simultaneous expression
of two distinct membrane- or chromatin-localized reporters
and a gene of interest in the same recombined cells (Figures
1D and S1A). This approach increases the cellular resolution
and the quantitative power of clonal functional analysis because
cell shape and number can both be quantified by immunostain-
ing or live imaging, allowing highly accurate tracking of the
mutant-cell morphology, migration, and proliferation (Figures
S1B and S1C; Movie S1). However, an inherent limitation of
this strategy for labeling cells with a given gene expression is
that although it allows us to visualize and quantify the shape
and number of cells expressing our gene of interest, we cannot
see the adjacent non-recombined wild-type cells at the same
resolution (Figure 1D). Therefore, this strategy does not allow
proper control of the phenotype caused by the genetic induction,
since it is not possible to appreciate local phenotypic differences
between mutant and control or wild-type cells. To overcome
these limitations, and be able to induce and label cell clones
with distinct gene expression in the same tissue in vivo, we
adapted a strategy based on multiple and mutually exclusive
LoxP sites that was previously used to generate the Brainbow
and Confetti mouse lines (Livet et al., 2007; Snippert et al.,
2010). With this approach, it is possible to induce multicolor
labeling and fate map different cells in a tissue expressing Cre
or CreERT2. However, existing DNA constructs and mouse lines
do not allow simultaneous tracking of a cell’s nucleus and mem-
brane; moreover, due to the closed DNA engineering strategy
used, existing constructs also do not allow the insertion and
mosaic co-expression of other genes of interest. In some of
the existing mouse lines, the expression of the different fluores-
cent proteins (FPs) cannot be distinguished by immunostaining
(Figure S1D) because they are derived from the same species
(like YFP, CFP, GFP) and thus have no unique epitopes.
Using inducible functional genetic mosaics to gain insight into
biological processes occurring in themouse requires a high level
of retrospective clonal and phenotypic resolution in order to infer
with high confidence how the mosaic cellular phenotype devel-
oped over time. For this, the endpoint clonal complexity/resolu-
tion needs to be high and clearly detectable by direct imaging or
immunostaining in order to obtain statistically significant data.
However, unlike simple fluorescent mosaics, to increase the
clonal resolution of functional genetic mosaics, we cannot rely
on combinatorial recombination of multicopy transgenes, like
in Brainbow mice (Livet et al., 2007), since it would generate a
mix of cells with combinatorial and unknown multiple gene, Cells, and Mice
ization of tissue architecture but not single cells.
ed reporter FPs, but only dual labeling (D) allows the full identification of a cell
on is only possible between identical Lox (L) sites (L1, L2, or L3). Therefore, Cre-
, B, C or D, E, F) that are mutually exclusive in any single cell. See Figure S2 for
saic and iChr-Mosaic), up to 15 different cell clones can be induced in the same
icate the single or dual color code for the clone.
s with different laser lines. See also Figure S2J.
osaic, iChr-Mosaic, and Cdh5(PAC)-CreERT2 alleles, 3 days after induction
solectinB4+ vascular tissue by scanning the endogenous fluorescence and
higher (J) magnification.
expression levels in a single cell. To significantly increase cell,
clone, and gene-function resolution, we designed a strategy
based on the induced recombination of just two types of
ifgMosaic constructs inserted in the Rosa26 locus (Figures 1E,
1F, and S2). With these constructs, we generated two types of
mouse lines. One allows the inducible expression of three mem-
brane-localized FPs (iMb-Mosaic) and the other the induction
of three chromatin-localized FPs (iChr-Mosaic), each with or
without the co-expression of other genes of interest. In ES cells
or F1-generation mice carrying both the iMb-Mosaic and the
iChr-Mosaic alleles, we can induce different combinations of
recombination to generate up to nine different cell clones with
dual labeling of the membrane (for cell shape) and chromatin/
nuclei (for cell unit count and proliferation analysis) and six other
clones with single membrane or nuclear labeling (Figures 1G and
1H). Thus, a total of 15 clones or up to six genes can be induced
in a stochastic/individual or combinatorial manner, allowing
study of their individual or combined function in different
cells of the same tissue. Contrasting the single probabilistic
and non-parallel recombination obtained with classical genetics
(Liu et al., 2013), the Dual iMb-Mosaic x iChr-Mosaic (Dual
ifgMosaic) strategy (Figures 1I and 1J) can support higher
recombination rates without compromising cellular, clonal, or
functional resolution because the probability of obtaining a given
dual color code is low and will correspond with 100% fidelity,
due to the viral 2A peptide (Trichas et al., 2008), to the defined
equimolar co-expression of one or two genes of interest. The
Dual ifgMosaic strategy is especially suited to genetic epistasis
analysis at single-cell or clonal resolution. The detection of adja-
cent cell clones expressing different combinations of genes and
marker proteins in the same tissue and field of view allows direct
measurements and phenotypic comparisons in the same envi-
ronmental context, a crucial step toward understanding the
precise role of genes in the cells forming a tissue. By developing
an open-source and high-throughput DNA engineering strategy,
we were able to rapidly generate several iMb- and iChr-Mosaic
constructs andmouse lines (Figure S2).With some of these lines,
it is only possible to induce the expression of FPs, which serve
as experimental mosaic controls, or provide a way of increasing
clonal complexity and resolution, whereas in other lines, the
expression of the different FPs is linked to the expression of
specific genes that modulate the function of different signaling
pathways.
Characterization of iChr-Notch-Mosaic and iMb-Vegfr2-
Mosaic ES Cells and Mice
As an example of the utility of the method and these new genetic
tools, we characterized the phenotype of genetic mosaics,
in which cells can have normal, low, or high Notch or VEGF
signaling. First, we evaluated the frequencies of recombination
and eventual toxicity of the induced FPs in the iMb-Control-
Mosaic and iChr-Control-Mosaic ES cell lines (Figures S2A
and S2E). 2 days after the transient transfection of these control
cell lines with Cre-expressing plasmids, we detected the
different FPs in different proportions, and these were maintained
after 8 days, showing that the expression of the different FPs per
se is not toxic and does not alter the long-term cell proliferative
behavior of cells (Figure S2I). As predicted from previous studies(Zheng et al., 2000), our results also confirm that in general there
is an inverse correlation between the genetic distance separating
the LoxP sites and the recombination frequency (Figures 2A
and S2I). This suggests that it is better to place the shortest
FP-gene cassettes in the first positions in order to have a more
even chance of recombination among the three open reading
frames (ORFs).
We next evaluated the functionality of these new ifgMosaic
constructs in ES cells and mice. We studied the proliferation,
migration, and differentiation of cells during neurogenesis and
angiogenesis, processes known to be controlled by the Notch-
and VEGF-signaling pathways. To induce the iChr-Notch-
Mosaic in vivo, we crossed our mouse line with the Polr2a-
CreERT2 mouse line (Guerra et al., 2003), injected tamoxifen at
embryonic day (E) 8.5, and collected embryos at E12.5 (Fig-
ure 2C). In the neural tube, single-progenitor cells proliferate
and obey domain boundaries in the ventricular zone (VZ), form-
ing stripes of neuronal progenitors (Briscoe and Small, 2015)
that later differentiate and migrate to the mantle zone (MZ).
The results obtained in iChr-Notch-Mosaic embryos indicate
that single neuronal progenitors, pulsed with tamoxifen at E8.5
and having normal Notch levels (H2B-Cherry+), proliferate to
give rise to more progenitors (Tuj1, Sox2+), and at E12.5,
only a subset of these had differentiated (Tuj1+, Sox2) and
were present in the MZ (Figures 2C, 2D, and S3B). This situation
is optimal for sustaining neurogenesis for long periods of
time and preventing progenitor exhaustion. Single-progenitor
cells expressing NICD-PEST. (H2B-Cerulean+), which increases
Notch activity (Bray, 2006; Louvi and Artavanis-Tsakonas, 2006),
differentiated poorly, and their progeny were found mainly in the
VZ at E12.5. Interestingly, most of the progenitors expressing
DN-Maml1 (H2B-GFP-V5+), which decreases Notch activity
(Maillard et al., 2004), form smaller clones because they commit
to differentiation precociously and move laterally to the MZ,
where terminally differentiated and non-proliferative cells accu-
mulate (Figures 2C, 2D, and S3B). Sox2+ progenitor cells with
higher Notch signaling also form smaller clones than the con-
trol/cherry+ cells, which proliferate and differentiate normally,
suggesting that even though opposing Notch levels produce
opposite cell-differentiation outcomes, they both result in
impaired neurogenesis and reduced expansion of individual pro-
genitor cells (Figure 2D). In addition to neurogenesis, we also
evaluated iChr-Notch-Mosaic frequencies during endothelial
cell (EC) differentiation from ES cells in vitro. Cells with low Notch
signaling seem to have a competitive advantage in this assay,
whereas ES cells with high Notch signaling cannot differentiate
into ECs (Figures 2E, S3C, and S3D). We also used the iMb-
Vegfr2-Mosaic mice to evaluate how ECs with different levels
of VEGFR2 signaling behave during angiogenesis (Figure 3A).
Cells expressing VEGFR2Ac. (MbTomato+), which activates
VEGFR2 signaling (Dosch and Ballmer-Hofer, 2010), have signif-
icantly higher levels of ERK phosphorylation, like endothelial-
sprouting tip cells, and are frequently found at the vessel tips
(Figures 3C and 3D). Cells expressing Vegfr2TK (MbYFP+), a
tyrosine kinase mutant form (Y1173) of murine Vegfr2 (Sakurai
et al., 2005), which binds VEGF and dimerizes with wild-type
VEGFR2, decreasing VEGFR2 signaling in a cell-autonomous
manner, exit cell-cycle during angiogenesis (Figure 3E). ES cellsCell 170, 800–814, August 10, 2017 803
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Figure 2. Inducible iChr-Notch-Mosaic ES Cells and Mice
(A) iChr-Notch-Mosaic DNA construct inserted in the Rosa26 locus. Below the genetic distance (kb) between different LoxP sites and the relative recombination
ratios obtained after Cre-expressing plasmid transfection.
(B) Representative picture of iChr-Notch-Mosaic ES cells expressing the different fluorescent proteins.
(C) Confocal micrographs of 20-micron thick cryosections immunostained for the indicated markers. The border between the marginal and ventricular zones is
indicated by a yellow line (see also Figure S3).
(D) Dot plot of individual clones. Error bars indicate SEM.
(E) Ratios of the recombined cells observed in ES cells and after differentiation to ECs. Below is shown a representative picture of an embryoid body (EB)-derived
endothelial monolayer.expressing Vegfr2TK (MbYFP+) cannot differentiate to ECs,
whereas some cells expressing VEGFR2Ac. (MbTomato+) can
differentiate but are outcompeted by the adjacent control
(Kate2+) cells (Figure 3F), even though MbTomato+ cells have
more VEGFR2 and ERK signaling. This surprising finding would
be impossible to obtain using classical genetics.
The Dual ifgMosaic Method Enables Multiple Mosaic
Epistasis Analysis in the Same Tissue and at High
Resolution
The results shown above highlight how genetic mosaics can be
induced and used to study the role of genes in distinct cell pop-
ulations. However, we very often need to understand the impact
of genes not on groups of cells but rather on single cells and to
understand their impact on single-cell heterogeneity. To accu-
rately track single-cell proliferation and migration over time
with the individual iMb-Mosaic or iChr-Mosaic mouse lines
described above, recombination needs to be induced at rela-
tively low frequencies to ensure single-cell or clonal resolution.
However, this results in few clones of recombined cells per tis-804 Cell 170, 800–814, August 10, 2017sue, and it is therefore rare with this methodology to observe
distinct clones in the same image-acquisition view, rendering
mosaic analysis more difficult and time consuming. To obtain a
higher number of clones and then track, with high accuracy,
the proliferative and migratory behavior of different individual
cells expressing different genes in the same tissue, we used
the Dual ifgMosaic strategy. As a first example, we show the
result of interbreeding the iChr-Notch-Mosaic and iMb-Control-
Mosaic mouse lines (Figures 4A). Instead of inducing and
analyzing only 3 distinct clones of cells, the Dual ifgMosaic strat-
egy allows the generation of up to 15 distinct cell clones, as
mentioned above (Figure 1), where only a subset of them have
a dual color-code (Figures 4B–4D). The low frequency of dual
recombination events makes it easier to identify, count the cell
number, and define the shape of adjacent cell clones expressing
up to three different genes in the same image-acquisition view,
thus enabling a much more precise quantification of the effect
of different genes on the proliferation, differentiation, and migra-
tion of individual cells over a pulse-chase period (Figures 4B–
4D). With this strategy, we could accurately quantify how many
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Figure 3. Inducible iMb-Vegfr2-Mosaic ES Cells and Mice
(A) iMb-Vegfr2-Mosaic DNA construct. Below the genetic distance (kb) between different LoxP sites and the relative recombination ratios obtained after Cre
transfection.
(B) Representative picture of iMb-Vegfr2-Mosaic ES cells expressing the different fluorescent proteins.
(C) Confocal micrographs showing the MbYFP- and MbTomato-expressing cells in a vasculature of a P6 mouse retina, 3 days after tamoxifen injection.
IsolectinB4 labels the surface and ERG the nuclei of all ECs. Each dot in the chart indicates the identified ratio of EC surface area occupied by MbTomato- and
MbYFP-expressing cells in each microscopic field.
(D) Immunostaining of retinal vessels for phospho-ERK. Charts show that P-ERK signals are higher in most tip cells (arrowhead) and in MbTomato+ cells (arrows).
(E) Immunostaining of retina ECs (nuclei, ERG+) for the indicatedmarkers 3 days after the tamoxifen pulse. Most YFP+ cells have no EdU labeling (arrows) and few
are EdU+ (pink nuclei, arrowhead inset).
(F) Embryoid bodies derived from ES cells were plated on a OP9monolayer to induce EC differentiation and sprouting. Colored bars indicate occurrence of each
cell population among all recombined cells at the ES cell stage and after differentiation to ECs.
In (D) and (E), error bars SD, *p < 0.05.times a single EC divides within a defined time window during
angiogenesis (Figure 4E). We could also determine the average
clonal-cell dispersion, according to its size (Figure S3F). To
accurately quantify and delimit the most frequent dual clones
in areas with higher recombination (Figure 4C), the average
clone-dispersion value (Figure S3F) can be used to define an
area (white squares in Figure 4C) that contains all cells of an in-
dividual clone.
With the Dual ifgMosaic strategy, it is also possible to perform
multiple and combinatorial mosaic epistasis analysis with high
temporal and cellular resolution, since it is possible to induce
a mosaic of cells where the expression of up to three genes
(A, B, or C) can be induced in combination with the expressionof any other three genes (D, E, or F). The Dual ifgMosaic method
therefore enables epistasis analysis of up to six genes or genetic
pathways in up to nine different expression combinations, at sin-
gle-cell resolution and in the same tissue. As an example, we
crossed the iChr-Notch-Mosaic and iMb-Vegfr2-Mosaic mice
to analyze how single cells with different combinations of Notch
and VEGF signaling proliferated over time when confronting the
same biological context (Figures 4F, 4G, and S3G). This analysis
revealed that activation of VEGFR2 signaling in high-Notch cells
does not significantly increase their proliferation (compare bars
AF in Figure 4G with 4E) and that single ECs with low VEGF
signaling, which generally do not proliferate, can divide and
generate larger clones when Notch signaling is low but notCell 170, 800–814, August 10, 2017 805
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when Notch signaling is high (BD vs BE vs BF in Figure 4G).
Surprisingly, we also found that a large fraction of single ECs
with simultaneous high VEGF and low Notch signaling, which
are both pro-mitogenic stimuli, do not proliferate, whereas
most single control or low-Notch cells proliferate well (compare
AE in Figure 4G with AE/BE or AD/BD in 4E, and see also S3G).
PB-Rosa26 BAC for Easy Recombineering of the
ifgMosaic and Robust Single-Copy Transgenesis
The induction of functional genetic mosaics with the ifgMosaic
strategy requires the genome integration of a large multi-ORF
construct as a single copy. We initially achieved this by gene
targeting of the safe-harbor Rosa26 locus in mouse ES cells
(Soriano, 1999). However, we encountered difficulties in cloning
these large plasmids, which can be as large as 30 kb (Figure S4A)
and contain multiple genes and repetitive sequences, including
the four insulators, six loxP sites, four transcription stop se-
quences, and FPs with very similar sequences (YFP, GFP, and
Cerulean). We also detected frequent stochastic deletions dur-
ing plasmid amplification. Assembling all these elements in a
single construct and screening out these sporadic deletions
was time consuming and made generation of the desired large
ifgMosaic constructs, with all the required elements for gene
targeting and induction, difficult and unpredictable. Once these
problems were overcome, we also had difficulties obtaining
mouse ES cell clones with correct targeting of the Rosa26 locus.
This is likely due to the large size of the ifgMosaic constructs and
the existence of multiple direct repeats. Using traditional gene-
targeting technology, inserts of up to 5 kb can be targeted to
the Rosa26 locus in mouse ES cells at a typical targeting effi-
ciency of 15%; but with DNA inserts of around 25 kb containing
multiple repeats, only 2% of clones were correctly targeted
(detected by PCR or Southern blot).
To overcome these problems, we devised new cloning strate-
gies to facilitate the assembly of the desired large multi-ORF
DNA constructs and a method that would also yield mice ready
for experimental breeding in only 3 months, instead of the typical
12 months required with classical gene targeting (Figure S4B).
Our method is based on the injection of an engineered Rosa26
BAC (bacterial artificial chromosome) together with transposase
RNA into mouse eggs (Figure 5A–5C). Compared with plasmids,
BACs are able to carry and replicate much larger quantities of
DNA (around 200–250 kb). We first modified an existing BACFigure 4. Single-Cell Resolution Epistasis Analysis with Dual ifgMosai
(A) iMb-Control-Mosaic and iChr-Notch-Mosaic mice were intercrossed with Cd
(B) Representative confocal micrographs of the retinas 3 days after tamoxifen indu
ifgMosaic mice.
(C) Composite image of the pictures showed in (B), where is possible to see the
clones.
(D) Highermagnification pictures of the boxed areas (C) allow visualization of the ce
were assigned to double recombined clones according to their membrane (A–C)
(E) Histogram showing the frequency and clone size of dual clones according to t
*p < 0.01.
(F) Schematic representation of the genetic constructs of iMb-Vegfr2-Mosaic an
vessels expressing the different combination of genes/FPs. On the right is shown
channels of each dual clone are shown in gray.
(G) Histogram showing the frequency and clone size according to their dual nucle
the median value for each type of clone. * p < 0,05.that includes 200 kb of the euchromatic Rosa26 locus, which is
known to be actively expressed in all mouse cells. By DNA re-
combineering in bacteria, we inserted several sequences that
together allowed us to generate robust transgenic and unicopy
ifgMosaic mice. The inserted sequences were as follows: the
piggyBac (PB) transposon inverted repeats, for efficient single
copy and complete BAC integration in the genome; four insulator
(INS) sequences flanking the required transcriptional units, to
decrease the probability of regulatory interference from neigh-
boring genomic regions; the strong and ubiquituous CAG
enhancer and promoter, to enhance gene expression; 3 kb
of DNA homology sequences, to promote efficient BAC-plasmid
DNA intermolecular recombineering in bacteria; and the N-PhiM
reporter of CAG promoter expression in the absence of Cre
activity (Figure 5A). N-PhiM is a noncytotoxic modified PhiYFP
gene (Evrogen) with a nuclear localization signal and lacking
endogenous fluorescence (Cai et al., 2013), and it can be de-
tected by immunostaining (Figure 5D). The inclusion of the large
3 kb homology sequences was necessary to outcompete intra-
molecular recombination between the several DNA repeats pre-
sent in these multi-ORF mosaic constructs. Recombineering the
engineered Rosa26 BAC in E. coli supported highly efficient in-
frame insertion of large ifgMosaic DNA fragments (up to 25 kb)
containing up to four large transcriptional units (Figure 5B). We
provide step-by-step guides for the rapid assembly of the donor
multi-ORF constructs, BAC recombineering, and screening for
the full integration of these constructs in the acceptor Rosa26
BAC through restriction enzyme analysis and simple gel electro-
phoresis (Figures S4C and S4D). Overall, this method signifi-
cantly simplifies the DNA cloning steps because the donor
vectors for BAC recombineering are 12 kb smaller than the final
classical gene-targeting vectors used to target the Rosa26 locus
(compare Figures S4A and S4D).
Having obtained the desired modified Rosa26 ifgMosaic BAC
(Figure S5A), we injected it together with the RNA encoding the
hyperactive piggyBac transposase (HyPBase) into fertilized
mouse eggs (Rostovskaya et al., 2013). The piggyBac transposi-
tion system allowed us to obtain on average 26% BAC-trans-
genic pups with complete genomic integration of a single BAC;
in contrast, standard methods of BAC linearization, purification,
and injection yielded only 3% transgenic offspring. The trans-
posase-dependent transgenesis method yielded on average
three founder animals from a single transgenesis session,c Mice
h5-CreERT2 mice and progeny analyzed at P6.
ction, showing the five different acquisition channels and FPs obtained in Dual
different clones of cells. White boxed areas delimitate some Dual ifgMosaic
ll shape and nuclei for quantification of clone size and distribution. Letter codes
or nuclear (D–F) color.
heir nuclear color (Notch-signaling level). Vertical lines indicate median values.
d iChr-Notch-Mosaic mice and representative confocal micrographs of retina
higher-magnification pictures of some dual fluorescent clones. Isolated color
i and membrane color (Notch- and VEGF-signaling level). Vertical lines indicate
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Figure 5. Rosa26 ifgMosaic BAC Recombineering and Transgenesis
(A) A BAC containing 195 kb of the euchromaticRosa26 locus was first modified to include the piggyBac (PB) transposon elements flanked by the ampicillin (Amp)
selection cassette and all the other elements necessary for robust BAC recombineering, transgenesis, and expression.
(B) Three-step pipeline for generating Rosa26 ifgMosaic BACs. (1) The desired genes (A–F) are cloned in frame downstream of the 2A-peptide sequences of each
construct. (2) Three individual DNA fragments (HindIII-BglII, BglII-SpeI, and SpeI-NotI) are obtained from the entry vectors and ligated simultaneously to an
existing acceptor vector (digested with HindIII/NotI) to generate the ifgMosaic donor vector. (3) This ifgMosaic donor vector includes two 1.5 kb homology arms
for precise and efficient BAC recombineering in E. coli, which allows the generation of theRosa26 ifgMosaic BAC. This BAC is then flipped in E. coli to remove the
FRT-PGK-Neo-FRT cassette and subsequently used for piggyBac-transposon-mediated transgenesis in mouse zygotes.
(C) Efficiency of the Rosa26 ifgMosaic BAC transgenesis method.
(D) Expression of the N-PhiM reporter indicates activity of the BAC Rosa26-INS-CAG promoter in transgenic lines with ubiquitous and variegated expression.
(E) Representative confocal micrograph of the retina vasculature of mice containing the BAC Rosa26 transgenic allele after tamoxifen induction of Cdh5-
CreERT2, which results in recombination and expression of the mosaic in ECs (IsolectinB4+).
(F) Additional modified acceptor Rosa26 BACs for Tre/Tet or UAS/Gal4 induction.representing significant time and cost savings. Screening of F1
transgenic mice containing these modified Rosa26 ifgMosaic
BACs revealed N-PhiM reporter expression in most cells of
32% of founders (Figures 5C and 5D), and reporter expression
was maintained across all generations examined, as with
classical Rosa26 locus gene targeting. The frequency of LoxP
recombination and the expression level of these transgenic
Rosa26 BACs are also identical to those observed with classical
Rosa26 gene targeting (Figure 5E). We also generated acceptor808 Cell 170, 800–814, August 10, 2017and Rosa26 BAC constructs containing the Tre-tight and up-
stream activating sequence (UAS) 4xnr promoters, which allow
titratable and reversible expression of the mosaic in cells ex-
pressing tTA/rtTA or Gal4, respectively (Figures 5F, S5B, and
S5C). With these DNA constructs, any laboratory can easily
generate ifgMosaic cell lines, zebrafish, or mice. In addition,
since the Rosa26 BAC integrates in the genome randomly and
not in the Rosa26 locus, the mouse lines can be crossed with
other available mouse lines containing other classical Rosa26
A B
E F
C D
Figure 6. Rosa26 ifgMosaic Gene Targeting in ES Cells
(A) Confocal micrographs showing expression of the N-PhiM reporter in BAC transgenic ES cells and differentiated ECs (Pecam+). All neomycin-resistant clones
show expression of the BAC in ES cells, but only 10% have robust expression in virtually all ES and ECs.
(B) Cas9-mediated gene targeting of a donor ifgMosaic vector into the endogenous Rosa26 locus, premodified to contain an acceptor construct with 3 kb of
homologous sequences and a Cas9 target sequence for highly efficient and precise gene targeting by homology-dependent double-strand break repair.
(C) Southern blot analysis of gene-targeted ES cell clones containing the acceptor construct in the Rosa26 locus.
(D) PCR screening reveals that 58% of neomycin-resistant ES cell clones have the desired integration of the ifgMosaic cassette into the premodified
Rosa26 locus.
(E) Expression of the N-PhiM reporter in gene-targeted ES cells and ECs (Pecam+).
(F) Induction of recombination in vitro in embryoid-body-derived ECs, showing mosaic expression of the three H2B- or Mb-tagged FPs in different ECs
(VE-cadherin+).knockin alleles. In summary, this method of BAC recombineering
and transgenesis allows the rapid and robust generation of sin-
gle-copy transgenic cells or animals ready for inducible mosaic
gene-function analysis.
CRISPR/Cas9-Mediated Integration of Large ifgMosaic
Constructs in a Pre-modified Rosa26 Locus inmESCells
Inducible genetic-fluorescent mosaics are also very useful tools
for studying the biology of stem cells and their differentiated
progeny in vitro. For example, the distribution of mosaic cell
ratios among the progeny of specific progenitor cells can reveal
how specific genes control the differentiation of certain cell
types. We transfected mouse embryonic stem (mES) cells with
the same modified BACs and hyperactive transposase plasmid
and used neomycin and qRT-PCR to select clones containing
a single copy of the genome-integrated BAC. Even though
95% of transgenic mES cell clones expressed the N-PhiM re-
porter, only 30% of them maintained reporter expression after
differentiation to ECs, and only 10% had expression in most
ES cells and ECs (Figure 6A). This result contrasts with the in vivo
findings, which showed ubiquitous and homogenous reporterexpression in 32% of the founders (Figures 5C and 5D). The
main difference between the in vivo and in vitro BAC transgene-
sis approaches is the use in stem cells of the PGK-Neo selection
marker to select the rare genomic integration events. This
cassette has been shown to induce upstream promoter silencing
(Ema et al., 2006). For the in vivo procedure, this cassette is
removed from all BACs before egg microinjection and transgen-
esis. Removal of the FRT-PGK-Neo-pA-FRT cassette from
BACs integrated in ES cells, by Flpe-encoding plasmid transfec-
tion, led to an increased frequency of N-PhiM reporter expres-
sion in only 25% of the transgenic clones (data not shown), at
the cost of doubling the time required to generate ifgMosaic
ES cells.
Given the weak improvement in BAC expression in vitro, we
explored strategies for direct gene targeting of the endogenous
Rosa26 locus in mouse ES cells. Classical gene targeting of
the large ifgMosaic constructs is very inefficient, with correct
gene targeting in only 2% of neomycin-resistant ES cell clones,
probably due to the large size and the presence of multiple
direct repeats in ifgMosaic constructs. We therefore decided to
test a new method of Rosa26 gene targeting—potentially moreCell 170, 800–814, August 10, 2017 809
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Figure 7. Second-Generation Improved iMb2-Mosaic and iChr2-Mosaic Constructs and Cell Lines
(A) Schematic illustration of the iMb2-Mosaic and iChr2-Mosaic DNA constructs (see also Figure S7).
(B) Live imaging and comparison of endogenous fluorescence intensity in the ifgMosaic and the improved ifg2Mosaic ES cell lines.
(C) Combinatorial Dual ifg2Mosaic endogenous fluorescence in ES cellular genetic mosaics after live scanning confocal microscopy or after immunostaning with
the indicated antibodies. Two-letter codes indicate the double-recombined cell clones and the observed combination of FPs A–F, confirming that it is possible to
distinguish all the cell clones in the same acquisition field and with the same microscopy settings for direct cell comparison.
(D) Expression of iMb2-Mosaic and iChr2-Mosaic in P6 mouse retina ECs using the inducible Cdh5-CreERT2 or Tie2-Cre mouse lines.
(legend continued on next page)
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efficient and compatible with the smaller donor multiple-ORF
ifgMosaic constructs that were used to recombine the Rosa26
BACs in bacteria (Figures 6B and 5B). Unlike classical Rosa26
gene-targeting constructs (Figure S4A), these are much easier
toconstruct because they lack the largehomology arms (required
for classical gene targeting), the CAG promoter and the insulator
sequences,making them12kbshorter.Wehypothesized that the
CRISPR/Cas system would significantly enhance homologous
recombination (HR) and the efficiency of gene targeting in a
pre-modified Rosa26 locus containing all the constant elements
present in all the ifgMosaic constructs. To test this, we first gener-
ated an acceptor mES cell line containing in the Rosa26 locus
the elements previously inserted in the acceptor Rosa26 BAC
(compare Figures 5A and 6B). In the center of this cassette, we
included a unique sequence to enable highly efficient and guided
CRISPR/Cas9-mediated DNA double-strand breakage (Fig-
ure 6B). Nucleofection of the new acceptor G4 mES cells, with
the previously generated donor multi-ORF ifgMosaic constructs
and the px330 plasmid encoding Cas9 and the unique single-
guide RNA (sgRNA) sequence, allowed us to induce double-
strandbreaks at the desired integration site. After 7 days of selec-
tion with neomycin, we picked clones from each ifgMosaic donor
plasmid nucleofection, finding that 58% of ES cell clones
had integration of the desired donor construct by homologous
recombination in the pre-modified Rosa26 locus (Figures 6C
and 6D). This method increased the efficiency of correct
Rosa26 gene-targeting of multi-ORF ifgMosaic constructs by
30-fold compared with classical gene targeting using large con-
structs (2%). Importantly, and in contrast with the in vitro BAC
transgenesis method, all the Rosa26-targeted clones had high
expression of the N-PhiM reporter in most stem cells and differ-
entiated progeny (Figure 6E). In addition, we could induce the ex-
pectedcellularmosaic in EScells anddifferentiated progeny (Fig-
ure 6F). Therefore, this novel acceptor EScell line and themethod
provided here greatly simplify the generation and targeting of
multi-ORF ifgMosaic constructs to the Rosa26 locus and can
be used for the high-throughput generation of multiple ifgMosaic
ES cell lines for in vitro-inducible genetic-fluorescent mosaic
analysis. The generated acceptor ES cells are from the G4 back-
ground and have a very high germline-transmission potential
(George et al., 2007). We successfully used them to generate
gene-targeted Rosa26 ifgMosaicmouse lines.
Design and Testing of Improved Versions of the
ifgMosaic Constructs
The experience gained from the analysis of the previous ifgMo-
saic ES cell lines and mice prompted us to develop improved
constructs (Figures 7A and S6A). These second-generation con-
structs (iMb2-Mosaic and iChr2-Mosaic) significantly enhance
the expression of the FPs and downstream functional genes (Fig-
ure 7B), which is important for high resolution and nontoxic live
imaging (Movie S2), and for better mosaic gene gain and loss-(E) Selected dual-labeled clones of retina vessels pulsed with tamoxifen once (
labeling obtained in Cdh5-CreERT2+ ECs, pulsed once with tamoxifen, or in emb
and grown on Puro for 3 days. ‘‘All’’ indicates the frequency of all recombined/fluo
frequencies change according to the level of Cre activity, which is higher in transof-function function analysis. In addition, the combination of pro-
teins and selected epitopes further facilitates the detection of the
Dual ifgMosaic by live imaging or after immunostaining (Figures
7C, 7D, S6B, and S6C), which is essential for high-throughput
mosaic quantitative analysis. During the development of iMb2-
Mosaic and iChr2-Mosaic constructs, we overcame some of
the limitations of previous ifgMosaic constructs. First, when the
ORF coding the fluorescent protein and the gene of interest is
large and contains one or two 2A peptide sequences, expression
of the functional genes and FPs is relatively low due to the
reported 2A-peptide-induced translation pause and ribosomal
skipping step (Sharma et al., 2012; Trichas et al., 2008). We over-
came this problem by including several genetic elements that
overall significantly increased the expression of the ifgMosaic
ORFs. For instance, we introduced in all ORFs the full consensus
KOZAK sequence (gccaccATGgcg) (Kozak, 1987), and the
WPRE element (Lee et al., 2005), which increases protein levels
by increasingmRNA translation and stability (Figures 7A and 7B).
Second, we included four insulators flanking the transcriptional
units, for higher expression of the CAG promoter. Third, the
membrane tag in the first-generation ifgMosaic constructs was
substituted with an improved membrane tag (De Paola et al.,
2003) to increase signal intensity at the membrane and decrease
the signal in the cytoplasm (Figure 7B). This is especially impor-
tant when an iMb-Mosaic is combined with an iChr-Mosaic, in
which the separation of nuclei and membrane signals is crucial
(Figure 7C, 7E, and S6C). And fourth, we noticed that the endog-
enous fluorescence of some proteins, such as Kate2, is reduced
when they contain tags that target them to the membrane or nu-
cleus or when they contain the 2A peptide in the C-terminal po-
sition (Figure 1E). To circumvent this problem, we used instead
Mb2-HA-Tfp1-2A, which is a brighter blue-green (teal) FP and
more compatible with the other FPs in the Dual ifg2Mosaic sys-
tem (Figures 7B–7E and S6). We next analyzed the frequency of
recombination obtained in Dual ifg2Mosaic ES cells transfected
with Cre-expressing plasmids and in mice carrying the Cdh5-
CreERT2 allele and pulsed once with tamoxifen. This analysis re-
vealed that the relative recombination ratios depend on the level
of Cre expression or induction, the genetic distance between
LoxP sites, and the nature of the DNA sequence of the mosaic
construct used (Figure 7E and S6A). The higher the Cre activity,
the more similar the recombination among the different LoxP-
flanked ORFs and the higher the frequency of dual-labeled
clones (Figure 7E). Overall, the relatively low frequency of each
dual and combinatorial recombination event enables higher res-
olution clonal analysis, both in situations of low or high Cre activ-
ity. Of note, the genetic distance between LoxP sites is an impor-
tant factor, but recombination is also influenced by the adjacent
genes and FPs DNA sequences, since iMb2-Control-Mosaic,
iChr2-Control-Mosaic, and iChr2-Notch-Mosaic ES cells and
mice have significantly different recombination patterns despite
very similar inter-LoxP distances (Figure S6A). We also clonedsee also Figure S6). Numbers indicate the frequencies of recombination and
ryonic stem cells (ESCs) transfected with Cre- and PuroR-expressing plasmids
rescent cells in the tissue. The relative single (Si.) and dual (Du.) recombination
fected ESCs.
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FRT sites in iMb2 and iChr2 mosaic constructs (Figures S7B and
S7D). The FRT-containing ifg2Mosaics can be induced by Flpo
or Flpo-ERT2 (Kranz et al., 2010; Lao et al., 2012). This expands
the flexibility of the method. As an example, when a Cre-depen-
dent iMb2-Mosaic allele is combined with an FlpO-dependent
iChr2-Mosaic allele, Dual ifgMosaics can be induced that are
dependent on two distinct recombination events that can occur
sequentially over time, in the same or in distinct cells. This en-
ables higher resolution cell-fate mapping or the study of sequen-
tial mosaic gene function and epistasis, which can be used to
define how two genes sequentially modulate a given cell-lineage
specification.
DISCUSSION
Previous DNA constructs and mouse lines based on the Brain-
bow technology (Livet et al., 2007; Snippert et al., 2010) enabled
the generation of fluorescent cellular mosaics but not genetic
functional mosaics. The first requires the assembly of up to
four relatively small cassettes encoding the desired FPs
downstream of different and mutually exclusive LoxP sites. To
generate constructs for fluorescent and genetic functional mo-
saics, the cloning strategy has to be significantly different due
to the larger size of the cloned genes and the required restric-
tion-site versatility and compatibility at each cloning step. We
therefore decided to implement new cloning strategies and
design novel constructs that could be easily used by any scien-
tist to insert genes of interest downstream of the FPs (Figures
S2 and S7). This greatly facilitates the assembly of the final
ifgMosaic constructs for direct transgenesis or gene targeting.
The use of the viral 2A peptide allows the level and type of FP
expression to be correlated with 100% certainty to the expres-
sion level of the downstream gene of interest. With the Brainbow
system, it is difficult to detect complex fluorescent mosaics sim-
ply by scanning of the endogenous signal after combinatorial
and stochastic recombination of multiple Brainbow constructs,
especially if the cells are not clearly spatially separated or
when the endogenous fluorescent signals are weak due
to intrinsic low expression or tissue fixation. With the Dual
ifgMosaic strategy, the complexity of the fluorescent mosaic
arises from the recombination not of multi-copy transgenes but
of just two Rosa26 gene-targeted or two Rosa26 BAC trans-
genic unicopy alleles (iMb-Mosaic and iChr-Mosaic). In addition,
distinction among the 15 recombination possibilities is based on
the detection of FPs that differ not only in their spectral profiles
but also in their epitopes and cellular localizations, allowing
simultaneous tracking of cell shape (membrane-localized FPs)
and number (nuclear-localized FPs) of each dual-recombined
cell clone by live imaging or immunostaining.
To achieve this, we had to investigate the different spectral
properties and in vivo toxicity of all available FPs (Cai et al.,
2013), identify which small-epitope tags could be used and
easily detected in vivo, and determine the availability of specific
and compatible antibodies (see STARMethods). The experience
gained led us to develop a second generation of functional
ifgMosaic constructs and mouse lines (iMb2-Mosaic and
iChr2-Mosaic) that not only enhances the expression of the
FPs and downstream functional genes but also facilitates simul-812 Cell 170, 800–814, August 10, 2017taneous detection of the several marker proteins in the same
tissue with only three laser channels or antibodies. This is critical
because most microscopes only allow detection of four to six
different signal combinations. Therefore, with the Dual ifgMosaic
strategy, the functional and complex genetic mosaics can be
detected in the context of other stained tissue markers, which
is very important for accurate localization of the different color-
coded clones within the tissue and quantitative phenotypic
analysis. This strategy not only supports multiplex dual labeling
of the membrane and chromatin in recombined cells for
higher-resolution analysis of the clone-cell number and shape
but also allows multiple and combinatorial genetic-epistasis
analysis at single-cell or clonal resolution, because the function
of three genes can be studied in the context of any other three
expressed genes.
We also present two methods that greatly simplify the gener-
ation of transgenic and gene-targeted ifgMosaic ES cell lines and
mice. The first method is based on Rosa26 BAC recombineering
and requires only standard DNA-cloning techniques and a
standard transgenesis service. This fast method generates adult
transgenic ifgMosaic animals, ready for breeding and experi-
ments, just 3 months after starting the DNA construct cloning
and requires only 2 weeks of hands-on time. With the second
method, Cas9-induced HDR (homologous-dependent recombi-
nation) between the ifgMosaic donor vector and the pre-modi-
fied Rosa26 allele occurs in more than half of the Neo-resistant
ES cell clones, allowing multiple ES cell lines to be generated
with different ifgMosaic constructs in only 2 weeks. The pheno-
type of these stem cells or their differentiated progeny can be
directly studied by high-throughput live imaging (Movie S2) or
FACS sorting (Figure S6A). The insulated Rosa26-CAG promoter
used is strong and ubiquitous (Muzumdar et al., 2007; Soriano,
1999), allowing induction of the ifgMosaic in any cell type. To pro-
vide higher versatility of mosaic induction in any cell or model or-
ganism, we also assembled ifgMosaic constructs with UAS- and
Tre-tight-inducible promoters and FlpO-inducible FRT elements.
In summary, these new DNA constructs (Figure S7), mice, and
methods will significantly ease high-resolution mosaic gene-
function analysis, which is crucial for distinguishing between
cell-autonomous and non-cell-autonomous gene functions.
The Dual ifgMosaic approach will additionally allow investigation
of how up to six genes or genetic pathways interact functionally
at the single-cell level when they are expressed in different com-
binations in cells facing the same environment. Since all the anal-
ysis with this approach can be done in the same animal, tissue,
or image acquisition field, phenotypic and statistical compari-
sons between different mutant and adjacent control cells will
be more insightful than those made with current standard
gene-function-analysis approaches, which require comparison
between cells present in separate control and mutant animals.STAR+METHODS
Detailed methods are provided in the online version of this paper
and include the following:
d KEY RESOURCES TABLE
d CONTACT FOR REAGENT AND RESOURCE SHARING
d EXPERIMENTAL MODEL AND SUBJECT DETAILS
B Animals
d METHOD DETAILS
B ifgMosaic Recombinant DNA
B BAC recombineering and preparation for
microinjection
B ES cell culture and CRISPR/Cas9 gene targeting in
pre-modified Rosa26 locus
B Embryoid Bodies and endothelial differentiation
B Immunostainings
B FACS and qRT-PCR analysis
B Microscopy
d QUANTIFICATION AND STATISTICAL ANALYSIS
B Selection and quantification of mosaic clone size and
dispersion
B P-ERK relative signal intensity quantification
B Statistical analysis
d DATA AND SOFTWARE AVAILABILITY
SUPPLEMENTAL INFORMATION
Supplemental Information includes seven figures, one table, and two movies
and can be found with this article online at http://dx.doi.org/10.1016/j.cell.
2017.07.031.
AUTHOR CONTRIBUTIONS
L.H., A.G.-S., I.R.-A, J.R.P., S.F.R., and S.D.O.-C. generated plasmids and
BAC constructs. S.P.-Q., L.H., A.H., M.F.-C., W.L., and R.B. analyzed the
recombination and expression of the constructs in the different mouse lines.
G.G., V.C.-G., I.G.-G., M.B., and R.B. generated and analyzed mouse ES
cell lines with classical or CRISPR-Cas9 gene-targeting techniques.
L.M.C.-R. gave expert advice and generated the mouse lines by BAC
transgenesis in fertilized eggs or blastocyst injection of modified ES cells.
M.S.S.-M. genotyped and organized the mouse colonies. S.P.-Q., L.H.,
M.F.-C., W.L., I.G.-G., and R.B. designed experiments and interpreted results.
R.B. and S.P.-Q. wrote the manuscript.
ACKNOWLEDGMENTS
This work was supported by grants to the PI R.B. from the Spanish Ministry
of Economy, Industry and Competitiveness (SAF2013-44329-P, SAF2013-
42359-ERC, and RYC-2013-13209) and European Research Council (ERC-
2014-StG - 638028). S.P.-Q., M.F.-C., and I.G.-G. were supported by PhD
fellowships from Fundacio´n La Caixa (CX-SO-2013-02, CX_E-2015-01,
and CX-SO-16-1, respectively). W.L. by a FP7-PEOPLE-2012-COFUND
GA600396 postdoctoral contract. We thank Simon Bartlett for English editing,
Ralf H. Adams for sharing the Cdh5(PAC)-CreERT2 mice, Jose Luis de La
Pompa for comments throughout the project and for sharing the Tie2-Cre
mice, Gonzalo Gancedo for the help with the mouse colony, Valeria Caiolfa
for the help with the microscopy, and all themembers of the CNIC gene target-
ing, transgenesis, cellomics, and microscopy units. The CNIC is supported by
MEIC/MINECO and the Pro CNIC Foundation and is a Severo Ochoa Center of
Excellence (SEV-2015-0505).
Received: February 27, 2017
Revised: May 2, 2017
Accepted: July 21, 2017
Published: August 10, 2017
REFERENCES
Bray, S.J. (2006). Notch signalling: a simple pathway becomes complex. Nat.
Rev. Mol. Cell Biol. 7, 678–689.Briscoe, J., and Small, S. (2015). Morphogen rules: design principles of
gradient-mediated embryo patterning. Development 142, 3996–4009.
Cai, D., Cohen, K.B., Luo, T., Lichtman, J.W., and Sanes, J.R. (2013). Improved
tools for the Brainbow toolbox. Nat. Methods 10, 540–547.
De Paola, V., Arber, S., and Caroni, P. (2003). AMPA receptors regulate dy-
namic equilibrium of presynaptic terminals in mature hippocampal networks.
Nat. Neurosci. 6, 491–500.
Dosch, D.D., and Ballmer-Hofer, K. (2010). Transmembrane domain-mediated
orientation of receptor monomers in active VEGFR-2 dimers. FASEB J.
24, 32–38.
Ema, M., Takahashi, S., and Rossant, J. (2006). Deletion of the selection
cassette, but not cis-acting elements, in targeted Flk1-lacZ allele reveals
Flk1 expression in multipotent mesodermal progenitors. Blood 107, 111–117.
George, S.H., Gertsenstein, M., Vintersten, K., Korets-Smith, E., Murphy, J.,
Stevens, M.E., Haigh, J.J., and Nagy, A. (2007). Developmental and adult
phenotyping directly from mutant embryonic stem cells. Proc. Natl. Acad.
Sci. USA 104, 4455–4460.
Guerra, C., Mijimolle, N., Dhawahir, A., Dubus, P., Barradas, M., Serrano, M.,
Campuzano, V., and Barbacid, M. (2003). Tumor induction by an endogenous
K-ras oncogene is highly dependent on cellular context. Cancer Cell 4,
111–120.
Hadjantonakis, A.K., and Papaioannou, V.E. (2004). Dynamic in vivo imaging
and cell tracking using a histone fluorescent protein fusion in mice. BMC Bio-
technol. 4, 33.
Kisanuki, Y.Y., Hammer, R.E., Miyazaki, J., Williams, S.C., Richardson, J.A.,
and Yanagisawa, M. (2001). Tie2-Cre transgenic mice: a new model for endo-
thelial cell-lineage analysis in vivo. Dev. Biol. 230, 230–242.
Kozak, M. (1987). An analysis of 50-noncoding sequences from 699 vertebrate
messenger RNAs. Nucleic Acids Res. 15, 8125–8148.
Kranz, A., Fu, J., Duerschke, K., Weidlich, S., Naumann, R., Stewart, A.F., and
Anastassiadis, K. (2010). An improved Flp deleter mouse in C57Bl/6 based on
Flpo recombinase. Genesis 48, 512–520.
Lao, Z., Raju, G.P., Bai, C.B., and Joyner, A.L. (2012). MASTR: a technique for
mosaic mutant analysis with spatial and temporal control of recombination
using conditional floxed alleles in mice. Cell Rep. 2, 386–396.
Lee, E.C., Yu, D., Martinez de Velasco, J., Tessarollo, L., Swing, D.A., Court,
D.L., Jenkins, N.A., and Copeland, N.G. (2001). A highly efficient Escherichia
coli-based chromosome engineering system adapted for recombinogenic
targeting and subcloning of BAC DNA. Genomics 73, 56–65.
Lee, Y.B., Glover, C.P., Cosgrave, A.S., Bienemann, A., and Uney, J.B. (2005).
Optimizing regulatable gene expression using adenoviral vectors. Exp.
Physiol. 90, 33–37.
Li, L., Tasic, B., Micheva, K.D., Ivanov, V.M., Spletter, M.L., Smith, S.J., and
Luo, L. (2010). Visualizing the distribution of synapses from individual neurons
in the mouse brain. PLoS ONE 5, e11503.
Liu, J., Willet, S.G., Bankaitis, E.D., Xu, Y., Wright, C.V., and Gu, G. (2013).
Non-parallel recombination limits Cre-LoxP-based reporters as precise indi-
cators of conditional genetic manipulation. Genesis 51, 436–442.
Livet, J., Weissman, T.A., Kang, H., Draft, R.W., Lu, J., Bennis, R.A., Sanes,
J.R., and Lichtman, J.W. (2007). Transgenic strategies for combinatorial
expression of fluorescent proteins in the nervous system. Nature 450, 56–62.
Long, M.A., and Rossi, F.M. (2009). Silencing inhibits Cre-mediated recombi-
nation of the Z/AP and Z/EG reporters in adult cells. PLoS ONE 4, e5435.
Louvi, A., and Artavanis-Tsakonas, S. (2006). Notch signalling in vertebrate
neural development. Nat. Rev. Neurosci. 7, 93–102.
Maillard, I., Weng, A.P., Carpenter, A.C., Rodriguez, C.G., Sai, H., Xu, L.,
Allman, D., Aster, J.C., and Pear, W.S. (2004). Mastermind critically regulates
Notch-mediated lymphoid cell fate decisions. Blood 104, 1696–1702.
Muzumdar, M.D., Tasic, B., Miyamichi, K., Li, L., and Luo, L. (2007). A global
double-fluorescent Cre reporter mouse. Genesis 45, 593–605.Cell 170, 800–814, August 10, 2017 813
Rostovskaya,M., Naumann, R., Fu, J., Obst, M., Mueller, D., Stewart, A.F., and
Anastassiadis, K. (2013). Transposon mediated BAC transgenesis via pronu-
clear injection of mouse zygotes. Genesis 51, 135–141.
Sakurai, Y., Ohgimoto, K., Kataoka, Y., Yoshida, N., and Shibuya, M. (2005).
Essential role of Flk-1 (VEGF receptor 2) tyrosine residue 1173 in vasculogen-
esis in mice. Proc. Natl. Acad. Sci. USA 102, 1076–1081.
Schindelin, J., Arganda-Carreras, I., Frise, E., Kaynig, V., Longair, M., Pietzsch,
T., Preibisch, S., Rueden, C., Saalfeld, S., Schmid, B., et al. (2012). Fiji: an
open-source platform for biological-image analysis. Nat. Methods 9, 676–682.
Sharma, P., Yan, F., Doronina, V.A., Escuin-Ordinas, H., Ryan, M.D., and
Brown, J.D. (2012). 2A peptides provide distinct solutions to driving stop-carry
on translational recoding. Nucleic Acids Res. 40, 3143–3151.
Snippert, H.J., van der Flier, L.G., Sato, T., van Es, J.H., van den Born, M.,
Kroon-Veenboer, C., Barker, N., Klein, A.M., van Rheenen, J., Simons, B.D.,
and Clevers, H. (2010). Intestinal crypt homeostasis results from neutral
competition between symmetrically dividing Lgr5 stem cells. Cell 143,
134–144.
Soriano, P. (1999). Generalized lacZ expression with the ROSA26 Cre reporter
strain. Nat. Genet. 21, 70–71.814 Cell 170, 800–814, August 10, 2017Srinivas, S., Watanabe, T., Lin, C.S., William, C.M., Tanabe, Y., Jessell, T.M.,
and Costantini, F. (2001). Cre reporter strains produced by targeted insertion
of EYFP and ECFP into the ROSA26 locus. BMC Dev. Biol. 1, 4.
Trichas, G., Begbie, J., and Srinivas, S. (2008). Use of the viral 2A peptide for
bicistronic expression in transgenic mice. BMC Biol. 6, 40.
Vooijs, M., Jonkers, J., and Berns, A. (2001). A highly efficient ligand-regulated
Cre recombinase mouse line shows that LoxP recombination is position
dependent. EMBO Rep. 2, 292–297.
Wang, Y., Nakayama, M., Pitulescu, M.E., Schmidt, T.S., Bochenek, M.L.,
Sakakibara, A., Adams, S., Davy, A., Deutsch, U., Lu¨thi, U., et al. (2010).
Ephrin-B2 controls VEGF-induced angiogenesis and lymphangiogenesis.
Nature 465, 483–486.
Zheng, B., Sage, M., Sheppeard, E.A., Jurecic, V., and Bradley, A. (2000).
Engineering mouse chromosomes with Cre-loxP: range, efficiency, and so-
matic applications. Mol. Cell. Biol. 20, 648–655.
Zong, H. (2014). Generation and applications of MADM-based mouse genetic
mosaic system. Methods Mol. Biol. 1194, 187–201.
Zong, H., Espinosa, J.S., Su, H.H., Muzumdar, M.D., and Luo, L. (2005).
Mosaic analysis with double markers in mice. Cell 121, 479–492.
STAR+METHODSKEY RESOURCES TABLEREAGENT or RESOURCE SOURCE IDENTIFIER
Antibodies
Rabbit Anti-GFP Clontech Cat# 632592; RRID: AB_2336883
Goat Anti-GFP Acris Antibodies Cat# R1091P; RRID: AB_1002036
Rabbit anti-Dsred Clontech Cat# 632496; RRID: AB_10013483
Rabbit Anti-tRFP-CF594 Biotium Cat# 20422; RRID: AB_2686890
Mouse Anti-HA-594 Thermo Fisher Cat# A-21288; RRID: AB_2535830
Mouse Anti-HA -647 Cell Signaling Cat# 3444S; RRID: AB_10693329
Mouse Anti-V5 -488 AbDSerotec Cat# MCA1360A488; RRID:
AB_770155
Guinea Pig anti-mKate2 Dawen Cai - University
Michigan
N/A
Rabbit anti tRFP/Kate2 Evrogen Cat# AB233; RRID: AB_2571743
Biotinilated Isolectin B4 Vector Cat# B-1205; RRID: AB_2314661
Rabbit anti-ERG Abcam Cat# ab110639; RRID: AB_10864794
Rabbit anti-Sox2 Millipore Cat# AB5603; RRID: AB_2286686
Rat anti-mouse VE-cadherin BD Biosciences Cat# 555289; RRID: AB_395707
Rabbit Anti-PhiYFP Evrogen Cat# AB602
Rabbit anti-Phospho-p44/42 MAPK (ERK) Cell Signaling Cat# 4370; RRID: AB_2315112
Mouse Anti-B-Tubulin III (neuronal) Sigma Cat# T8578; RRID: AB_1841228
Chemicals, Peptides, and Recombinant Proteins
Hoechst 33342 Invitrogen H1399
Critical Commercial Assays
Click-it EdU Alexa Fluor 647 Imaging kit Thermo Fisher C10340
High Capacity cDNA kit Thermo Fisher 4368814
Mouse Gene Expression Taqman assays Thermo Fisher Diverse Codes
Taqman Universal PCR Master Mix Thermo Fisher 4304437
Experimental Models: Cell Lines
E. Coli XL1 Blue - Ultracompetent Agilent #200249
E. Coli EL250 CNIC Lee et al., 2001
G4 Mouse ES cells Andreas Nagy George et al., 2007
G4 Mouse ES cells: iMb-Control-Mosaic Gt(Rosa)26Sortm1(iMb-Control-Mosaic) This Paper N/A
G4 Mouse ES cells: iMb-Notch-Mosaic(Gt(Rosa)26Sortm1(iMb-Notch-Mosaic)) This Paper N/A
G4 Mouse ES cells: iMb-Vegfr2-Mosaic This Paper N/A
G4 Mouse ES cells: iChr-Control-Mosaic This Paper N/A
G4 Mouse ES cells: iChr-Notch-Mosaic This Paper N/A
G4 Mouse ES cells: iChr-Notch-v2-Mosaic This Paper N/A
G4 Mouse ES cells: iMb2-Control-Mosaic This Paper N/A
G4 Mouse ES cells: iChr2-Control-Mosaic This Paper N/A
G4 Mouse ES cells: iChr2-Notch-Mosaic This Paper N/A
G4 Mouse ES cells: Dual iMb x iChr Mosaic This Paper N/A
G4 Mouse ES cells: Dual iMb2 x iChr2 Mosaic This Paper N/A
(Continued on next page)
Cell 170, 800–814.e1–e7, August 10, 2017 e1
Continued
REAGENT or RESOURCE SOURCE IDENTIFIER
G4 Mouse ES cells: Acceptor ES cells for ifgMosaic targeting in
pre-modified Rosa26 locus
This Paper N/A
OP9 cells ATCC CRL-2749
Experimental Models: Organisms/Strains
Mouse: iMb-Control-Mosaic (Gt(Rosa)26Sortm1(iMb-Control-Mosaic)) This Paper N/A
Mouse: iMb-Notch-Mosaic(Gt(Rosa)26Sortm1(iMb-Notch-Mosaic)) This Paper N/A
Mouse: iMb-Vegfr2-Mosaic (TgBAC(Rosa)26Sor(iMb-Vegfr2-Mosaic)) This Paper N/A
Mouse: iChr-Control-Mosaic (Gt(Rosa)26Sortm1(iChr-Control-Mosaic)) This Paper N/A
Mouse: iChr-Notch-Mosaic (Gt(Rosa)26Sortm1(iChr-Notch-Mosaic)) This Paper N/A
Mouse: iChr-Notch-v2-Mosaic (TgBAC(Rosa)26Sor(iChr-Notch-v2-Mosaic)) This Paper N/A
Mouse: iMb2-Control-Mosaic (Tg(Rosa)26Sor(iMb2-Control-Mosaic)) This Paper N/A
Mouse: iChr2-Control-Mosaic (Gt(Rosa)26Sortm1(iChr2-Control-Mosaic) This Paper N/A
Mouse: iChr2-Notch-Mosaic (Gt(Rosa)26Sortm1(iChr2-Notch-Mosaic) This Paper N/A
Mouse: Tie2-Cre CNIC Kisanuki et al., 2001
Mouse: Cdh5(PAC)-CreERT2 CNIC Wang et al., 2010
Mouse: Polr2a-CreERT2 CNIO/CNIC Guerra et al., 2003
Oligonucleotides
See Table S1 Sigma N/A
Recombinant DNA
pmKate2-H2B Evrogen FP311
CMV-Brainbow-1.1 M Livet et al., 2007 Addgene # 18722
pThy1-Brainbow3.2 Cai et al., 2013 Addgene # 45179
p3-H2B-Cherry Nadia Mercader Lab N/A
Mb2-HA-Tfp1 Genscript DNA synthesis N/A
pCAG:H2B-EGFP Hadjantonakis and
Papaioannou, 2004
Addgene # 32599
pLVX-Tight-Puro Clontech N/A
pcDNA3.1 Invitrogen N/A
piiTRE-Bi-SG-Tii Li et al., 2010 Addgene # 26121
Vegfr2 active form Kurt Ballmer-Hofer Lab Dosch and Ballmer-Hofer 2010
Rosa26 BAC bacpac.chori.org RP23-401D9
pRosa26 Philipe Soriano Soriano, 1999
iMb2-Control-Mosaic (SO273) This paper, Figure S6 Addgene # 99750
iChr2-Control-Mosaic (SO274) This paper, Figure S6 Addgene # 99751
iChr2-Notch-Mosaic (SO250) This paper, Figure S6 Addgene # 99752
iMb-Control-Mosaic (IR98.10) This paper, Figure S2 Addgene # 99748
iMb-Notch-Mosaic (IR99.40) This paper, Figure S2 Addgene # 99749
LoxP1-Mb2YFP-2A (SO244) This paper, Figure S7 Addgene #99613
LoxP2-Mb2Tomato-2A (SO240 This paper, Figure S7 Addgene #99614
LoxP3-Mb2-HA-mTFP1-2A (SO157) This paper, Figure S7 Addgene #99615
LoxP1-His-H2B-Cherry-2A (SO290) This paper, Figure S7 Addgene #99616
LoxP2-H2B-EGFP-V5-2A (SO107) This paper, Figure S7 Addgene #99617
LoxP3-HA-H2B-Cerulean-2A (SO104) This paper, Figure S7 Addgene #99618
FRT1-Mb2YFP-2A (IG153) This paper, Figure S7 Addgene #99619
FRT2-Mb2Tomato-2A (IG154) This paper, Figure S7 Addgene #99620
FRT3-Mb2-HA-mTFP1-2A (IG155) This paper, Figure S7 Addgene #99621
FRT1-His-H2B-Cherry-2A (IG156) This paper, Figure S7 Addgene #99622
FRT2-H2B-EGFP-V5-2A (IG157) This paper, Figure S7 Addgene #99623
(Continued on next page)
e2 Cell 170, 800–814.e1–e7, August 10, 2017
Continued
REAGENT or RESOURCE SOURCE IDENTIFIER
FRT3-HA-H2B-Cerulean-2A (IG158) This paper, Figure S7 Addgene #99624
Triple ORF LoxP ifgMosaic Donor (LH208) This paper, Figure S7 Addgene #99625
Triple ORF FRT ifgMosaic Donor (IG135) This paper, Figure S7 Addgene #99626
pRosa26-4x-Insulator (JP6) This paper, Figure S7 Addgene #99627
pX330 Rosa26 AscI LH291 Gu1 (LH500) This paper, Figure S7 Addgene #99628
pX330 Rosa26 Gu1 (LH416) This paper, Figure S7 Addgene #99629
Tre-Tight ifgMosaic donor Vector (LH121) This paper, Figure S7 Addgene #99630
4xnr UAS ifgMosaic donor Vector (IG230) This paper, Figure S7 Addgene #99631
pRosa26-Acceptor (AG103) This paper, Figure S7 Addgene #99632
BAC Rosa26 iMb-Vegfr2-Mosaic (G273) This paper, Figures 3,
S2, and S5
N/A
BAC Rosa26 iChr-Notch-V2-Mosaic (G280) This paper, Figures S2
and S5.
N/A
BAC Rosa26 iMb VEGFR3/VEGFR2 Mosaic (G234) This paper, Figure S5 N/A
BAC Rosa26 iMb-Notch-V2-Mosaic (G203) This paper, Figure S5 N/A
BAC Rosa26 iMb-Notch-V3-Mosaic (G210) This paper, Figure S5 N/A
BAC Rosa26 iMb-Control-V2-Mosaic (G208) This paper, Figure S5 N/A
BAC Rosa26 iChr-Control-V2-Mosaic (G284) This paper, Figure S5 N/A
BAC Rosa26 4xnrUAS-iMb-Notch-Mosaic (G267) This paper, Figure S5 N/A
BAC Rosa26 4xnrUAS-iMb-Vegfr2-Mosaic (G276) This paper, Figure S5 N/A
BAC Rosa26 Tre-Tight-iMb-VEGFR3/2 Mosaic (G237) This paper, Figure S5 N/A
BAC Rosa26 CAG Acceptor (G226) This paper, Figure S7 N/A
BAC Rosa26 Tre-Tight Acceptor (G228) This paper, Figure S7 N/A
BAC Rosa26 4xnrUAS Acceptor (G256) This paper, Figure S7 N/A
Software and Algorithms
DNAstar SeqBuilder software Lasergene https://www.dnastar.com/
t-seqbuilder.aspx
Fiji Schindelin et al., 2012 https://imagej.net/Fiji
Leica SP5 and SP8 Confocal Software Leica http://www.leica-microsystems.com
ZEISS LSM700 and LSM780 Confocal software Zeiss https://www.zeiss.com/
global/home.htmlCONTACT FOR REAGENT AND RESOURCE SHARING
Further information and requests for reagents should be directed to andwill be fulfilled by LeadContact, Rui Benedito (Rui.benedito@
cnic.es).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Animals
To generate Rosa26 gene-targeted mice (Mus musculus) a G4 mES cell line with high germline transmission potential (George
et al., 2007) was used to perform Rosa26 gene targeting with different ifgMosaic constructs by the institute gene targeting facility
using standard methods. To generate transgenic mice containing the Rosa26 ifgMosaic BAC, 2ng/ul of the BAC Maxiprep
was co-injected with 100ng/ul of HyPBase transposase RNA in the pronucleus of fertlized mouse eggs by the host institute
transgenesis service. Several mouse lines (Figures S2, S5 and S6) were generated for this study, and images of nine
of these lines are shown in this study. This includes mouse lines iMb-Control-Mosaic (Gt(Rosa)26Sortm1(iMb-Control-Mosaic));
iMb-Notch-Mosaic (Gt(Rosa)26Sortm1(iMb-Notch-Mosaic)); iMb-Vegfr2-Mosaic (TgBAC(Rosa)26Sor(iMb-Vegfr2-Mosaic)); iChr-Control-
Mosaic (Gt(Rosa)26Sortm1(iChr-Control-Mosaic)); iChr-Notch-Mosaic (Gt(Rosa)26Sortm1(iChr-Notch-Mosaic)); iChr-Notch-v2-Mosaic
(TgBAC(Rosa)26Sor(iChr-Notch-v2-Mosaic)); iMb2-Control-Mosaic (Tg(Rosa)26Sor(iMb2-Control-Mosaic)); iChr2-Control-Mosaic
(Gt(Rosa)26Sortm1(iChr2-Control-Mosaic)) and iChr2-Notch-Mosaic (Gt(Rosa)26Sortm1(iChr2-Notch-Mosaic)). To induce the genetic mosaic in
ECs we used the transgenic mouse lines Tie2-Cre (Kisanuki et al., 2001) or Cdh5(PAC)-CreERT2 (Wang et al., 2010). To induceCell 170, 800–814.e1–e7, August 10, 2017 e3
the genetic mosaics in the neural tube we used the Polr2a-CreERT2 mouse line (Guerra et al., 2003). To activate recombination in
animals containing these CreERT2 alleles, tamoxifen (Sigma) was injected in pups at the indicated stages (35mg/g) or in combination
with progesterone in pregnant adult females (2mg tamoxifen and 1mg progesterone). Male and female mice were used for the anal-
ysis, which were maintained under specific pathogen-free conditions. Genotyping primers are provided in Table S1. Experiments
involving animals were conducted in accordance with institutional guidelines and laws, following protocols approved by local animal
ethics committees and authorities.
METHOD DETAILS
ifgMosaic Recombinant DNA
The basic elements of the different ifgMosaic constructs were obtained from different sources and assembled by standard DNA clon-
ing methods. The unique restriction sites and the sequential modular cloning strategy were designed and selected by using the
DNAstar SeqBuilder software (Lasergene) and previous experience with commercially available restriction enzymes. The TdTomato
DNA sequence was obtained by PCR from genomic DNA of the Rosa26 mT/mG mouse line (Muzumdar et al., 2007). mKate2
sequence was obtained from the pmKate2-H2B vector (FP311, Evrogen). Cerulean, EYFP, N-PhiMut, modified loxP sites and the
sv40 polyadenylation sequences were obtained from Addgene plasmids CMV-Brainbow-1.1 M and pThy1-Brainbow3.2, a gift
from Joshua Sanes (Addgene plasmids # 18722 and # 45179). H2B-Cherry was obtained from p3-H2B-Cherry (a gift from Nadia
Mercader). Mb2-HA-Tfp1 or FRT sites containing cassettes were synthesized at Genscript. The 41 aminoacids coding the Mb2
tag sequence of this construct was subsequently subcloned by PCR and fused to EYFP, EGFP and TdTomato. The H2B tag
and EGFP were obtained from pCAG:H2B-EGFP a gift from Anna-Katerina Hadjantonakis & Virginia Papaioannou (Addgene
plasmid # 32599). The WPRE and Tre-Tight sequences were obtained from pLVX-Tight-Puro (Clontech). The bGH polyadenylation
sequences were obtained from pcDNA3.1 (Invitrogen). The 2A peptide sequence of the Thosea asigna virus (TaV) was subcloned by
PCR. The insulator sequences were obtained from plasmid piiTRE-Bi-SG-Tii, a gift from Liqun Luo (Addgene plasmid # 26121). The
Cdh5 gene short 3’ homology sequence was obtained by PCR. The VEGFR2 active form, with a deletion of the extracelular domain,
was cloned from pcDNA3_hVegfr2-DeltaEC-V6E vector, a gift from Kurt Ballmer-Hofer. The Vegfr2TK version was obtained by
cDNA PCR amplification and mutagenesis (Y1173F) of the mouse gene Vegfr2 (Kdr). The DN-Maml1 and NICD-PEST sequences
were subcloned by PCR from mouse cDNA and following previous work (Maillard et al., 2004). The gene targeting construct used
to generate the ifgMosaic mouse lines obtained by classical Rosa26 gene targeting, is a modified version of the plasmid pRosa26
(Soriano, 1999). It includes a smaller backbone and several rare restriction sites flanking the homology arms, that due to their longer
sequence, are unlikely to cut any other subcloned cassete or gene of interest. These are used to linearize and remove the vector
backbone of the large ifgMosaic plasmids before classical or Cas9 assisted Rosa26 gene targeting.
To generate the BAC transgenic ifgMosaic constructs and mice, we modified an existing BAC (RP23-401D9) containing 190kb of
the mouse Rosa26 locus. In the backbone of this BAC we introduced the PiggyBAC transposon elements flanked by an Ampicillin
resistance gene expressing cassette (Rostovskaya et al., 2013), to select for recombinant BACs in EL250 bacteria. Later we intro-
duced by DNA recombineering the assembled cassette INS-INS-CAG-Promoter-L1L2L3-N-PhiM-pA-3-homology-FRT-PGK-Neo-
FRT-INS-INS, that allow us later to introduce any donor ifgMosaic construct containing up to 3 different ORFs flanked by three
different loxP sites. For the method used to clone the genes of interest and assemble all the different modular constructs into the
ifgMosaic donor vector see Figures 5, 7, S4 and S7. Plasmids generated for this study were deposited at Addgene (accession
numbers in key resources table). Bacterial clones containing the BACs used in this study are available upon request.
BAC recombineering and preparation for microinjection
The preparation of electrocompetent EL250 cells, transformation with the Rosa26 BAC and recombineering was carried out accord-
ing to previous protocols (Lee et al., 2001). After obtaining EL250 bacteria containing the acceptor Rosa26 BAC we induced homol-
ogous recombination with donor vectors by heat activating the EL250 lambda prophage recombination machinery after electropo-
ration. Briefly, the bacterial culture was grown overnight at 30C in Luria–Bertani (LB) broth without salt and with chloramphenicol
(12.5 mg/ml). In a 250 ml conical flask containing 25ml of LB broth we diluted (1:50) the overnight culture and incubated at 30C until
reaching an OD600 of 0.2. Then, 12 ml of culture were transferred to a pre-warmed 250 ml conical flask and heat-shocked at 42
C for
10 min in a shaking incubator (induced sample). The remaining culture was kept as the non-induced control. The two samples,
induced and non-induced, were cooled down in ice for 10 min and then transferred to two 15 ml Falcon tubes and pelleted by
centrifugation (1000g at 4C for 8 min). The supernatants were poured off and the pellets were gently resuspended in 1 ml ice-
cold Milli Q water. Subsequently, the samples were transferred to 1.5 ml tubes and were spun down using 20000g for 20 sec.
Then, pellets were washed with 1ml of Milli Q water twice. Finally, the pellets were resuspended in 40 ml of 10% glycerol in water
and stored on ice. 200 ng of linearized ifgMosaic Donor vector (maximum volume of 10 ul) were added to the non-induced and
induced samples, and then up to 50ul of the mixes were transferred in a 0.1 cm cuvette for electroporation (BioRad, California,
USA). A voltage of 1.8 (V/cm3), and an electric pulse of 1.5 to 5 (msec) was used. Immediately after, the transformed bacterial cells
were incubated in 500 ml of LB for 1 h at 30C. 100 ml of each transformation was spread out in LB plates supplemented with chlor-
amphenicol (12,5mg/ml) and kanamycin (12,5mg/ml) for selection of the bacteria containing the recombinantRosa26 ifgMosaicBACs.
The number of colonies obtained in the induced versus the non-induced plates was on average between 10 to 50 times higher. Singlee4 Cell 170, 800–814.e1–e7, August 10, 2017
colonies were screened, by BAC DNA Miniprep and restriction analysis with PmeI/AscI enzymes. The acceptor Rosa26 BAC DNA
was used as negative control. The FRT-PGK-Neo-FRT 3’ homology-FRT cassette was removed by inducing the expression of the
FLPe gene present in EL250 bacteria with arabinose. For this purpose, positive colonies were grown up to O.D.600=0.8 in LB.
Then, L-arabinose was added to the culture to get a final concentration of 0.2%, and bacteria were incubated at 30C for 1 h. After
that the culture was diluted 1:10 and incubated at 30C for 2 h. 1ul of the culture was plated in a chloramphenicol (12.5 mg/ml) LB
plate and 10ul of the culture were plated in a kanamycin (12.5 mg/ml) LB plate (as negative control). The number of colonies in
the Chloramphenicol plate was much higher than in the Kanamycin plates, confirming that most bacteria had recombined the
Neo/Kanamycin resistance cassette. To further confirm the structure of the flipped Rosa26 BAC after the entire procedure, we per-
formed a final AscI/PmeI restriction digestion analysis that allows us to confirm the integrity of the ifgMosaic construct inserted in the
Rosa26BAC. A single colony containing the final flippedRosa26 ifgMosaicBACwas grown overnight in PXYTmedia at 30C. Amodi-
fied Qiagen Maxiprep protocol (Appendix A within the Qiagen Maxiprep protocol) was used to obtain on average around 200-
500ng/ul of BAC DNA in 100ul of water or microinjection buffer. This solution was kept at 4C for not more than one month before
microinjection.
ES cell culture and CRISPR/Cas9 gene targeting in pre-modified Rosa26 locus
Mouse ES cells with the G4 background (George et al., 2007) were cultured in standard ES cell media (DMEM containing Glutamax
(31966-047, Gibco), 15% FBS (tested for germline transmission), 1 x NEAA (Hyclone, SH3023801), 0.1% ß-mercaptoethanol (Sigma,
M7522), 1 x Pen/Strep (Lonza, DE17-602E) and LIF) in dishes covered with a feeder layer of mouse embryonic fibroblasts (MEFs). For
classical gene targeting of large plasmids, 25ug of linearized DNA was used to electroporate 5 million cells. Selection in 200ug/ml
G418 (Geneticin) was performed for 6 days, after which individual colonies were picked for storage, PCR and Southern blot
screening. Selected positive clones were expanded and used for microinjection in host blastocysts of the C57Bl/6J strain. Chimeras
with high percentage of agouti coat color were then crossed with mice to obtain germline transmission of the targeted insertion. To
generate the ifgMosaic acceptor mouse ES cell line, we first used the same standard gene targeting procedurementioned above and
the ifgMosaic recipient vector that contains a FRT-PGK-Neo-FRT cassette for selection (Figure 6B). Afterwards we used transient
transfection with a Flpo expressing plasmid to remove the FRT-PGK-Neo-FRT cassette. This allowed us to perform additional tar-
getings of the pre-modified Rosa26 locus that contains all the necessary regulatory elements and an unique sequence for DNA
double-strand break (DSB) with Cas9 (Figure 6B). To generate Rosa26 ifgMosaic ES cell lines we used this modified G4 ES cell
line and performed nucleofection (Amaxa) with two plasmids. One expresses the sgRNA and the Cas9 protein (px330_U6_Gu1
Rosa26_CBh_hSpCas9) and the other is a donor ifgMosaic plasmid that will be used as template for DSB repair by homologous
recombination. For each nucleofection we ressuspended 2.5 million ES cells in 100ul volume containing 1.5ug of circular px330
plasmid and 3.5ug of the circular donor plasmid. After nucleofection we plated 5ul or 30ul of the mix in two different wells on a
6-well plate with MEFs. Six days after G418 selection, 12 isolated ES cell colonies were picked for storage and further screening.
PCR with the flanking primers GTGGGCTCTATGGCTTCTGA and ACTCCAGGACGGAGTCAGTG, allowed us to identify ES cell
clones with precise homologous recombination and insertion of the ifgMosaic cassette. After identification of clones with precise
gene targeting, we further validated the ifgMosaic functionality by transfecting the ES cells with a Cre expressing plasmid. Strong
expression of the 3 FPs in different cells further confirmed the ifgMosaic gene targeting and screening method since the donor
plasmid does not contain the CAG enhancer, and it will be only expressed after proper gene targeting in the pre-modified
Rosa26 locus.
Embryoid Bodies and endothelial differentiation
To generate embryoid bodies (EBs) from ES cells we used the standard hanging drop method. Briefly ES cells were first grown
for 2 days on gelatinized plates and after, tripsinized and ressuspended at a density of 60.000 cells per ml in embryoid bodies media
(DMEM Glutamax (Gibco, 31966-047), 15% FBS, HEPES (Biowhittaker EE17-737) and Monotyoglycerol (Sigma, M6145). For each
EB, 20ul drops of this solution were pipetted onto the lid of a petri dish. This lid was inverted, to form the hanging drops, and the dish
further filled with PBS to prevent evaporation. Four days after differentiation the embryoid bodies were plated on an OP9 cells mono-
layer and differentiated in basal media (MEM alpha (Gibco, 11900-016), supplemented with 20% FBS and 7.5%Sodium bicarbonate
(Gibco, 25080-060)) containing 30ng/ml of VEGF to further induce endothelial differentiation and proliferation for 5 days.
Immunostainings
For immunostaining of ES cells or ECs derived from embryoid bodies, cells were fixed for 10 minutes in PBS containing PFA4% and
Sucrose 4%. After a brief rinse in PBS, cells were permeabilized in 0.1% Triton for 10 minutes and then immersed in a blocking so-
lution (10% Fetal bovine serum in PBS). Primary antibodies (see Key Resources Table in STAR Methods) were diluted in blocking
solution and incubated for 2 hours at room temperature or overnight, followed by three washes in PBS of 10 minutes each and in-
cubation for 1 to 2 hours with conjugated secondary antibodies (Invitrogen or Biotium) at room temperature. After three washes in
PBS, cells were mounted with Fluoromount-G (SouthernBiotech).
For immunostaining of mouse retinas, eyes from mouse pups were dissected and fixed for 1 hour in a solution of PFA4% in
PBS. After washing the tissue in PBS twice, retinas were microdissected and processed for immunostaining following a very similarCell 170, 800–814.e1–e7, August 10, 2017 e5
protocol previously described above for the cells. The only difference is that the blocking/permeabilization buffer contains 0.3%
Triton, 3% FBS, 3% Donkey Serum and antibody washes were more extended in time; on average for 30 minutes each.
FACS and qRT-PCR analysis
For routine analysis of fluorescent protein ratios obtained in ES cells we lipofected them with Cre expressing plasmids and 3 days
after collected the cells for FACSAria analysis. In some cases these ES cells were differentiated to embryoid bodies and endothelial
cells, as shown above, and after trypsinization, cells were analysed in a FACSAria containing lasers to detect Cerulean/Tfp1, GFP/
YFP and Tomato/Cherry.
For the qRT-PCR analysis, endothelial cells were isolated fromE10.5mouse embryos or postnatal day 20mouse hearts. Cells were
immunolabelled with CD31-APC antibody and separated, according to their fluorescence, in a FACSAria. Cells were sorted directly
to RNeasy Mini Kit RLT buffer (Qiagen). RNA was extracted according to the Qiagen protocol. cDNA was synthetized with the High
Capacity cDNA kit from Applied Biosystems (AB). cDNA was quantified by qRT-PCR with Taqman assays and universal master mix
on a AB 7900 qRT-PCR machine.
Microscopy
Depending on the complexity of the immunostainings and the combination of FPs to detect, we used different laser-scanning
confocal microscopes. For up to 4 channels acquisition of large fields we used the ZEISS LSM700 inverted microscope with laser
lines 405, 488, 546 and 633nm. For multi-color detection of up to 7 different signals we used the inverted Leica SP5 confocal
(405, 488, 514, 546, 594, 633nm) or the Leica SP8 confocal with a 405nm laser and a white laser that allows excitation at any wave-
length from 470nm to 670nm. Occasionally, a ZEISS LSM780with a GaAsP spectral detector was used. To record theMovies S1 and
S2, we used a Leica SP5 confocal with a sensitive hybrid detector and with an incubation chamber for temperature (37C) and CO2
control (5% CO2). We used multi-well slides (IBIDI) containing the ES cells growing on top of a monolayer of MEFs and a 20x multi-
immersion objective covered with glycerol. Tile scan and volume (3D) acquisition was performed every 15 minutes for a period of
16 hours. For the mouse retina laser scanning confocal analysis we used the 10x, 20x or 40x lens. Individual fields or tiles of large
areas were acquired.
QUANTIFICATION AND STATISTICAL ANALYSIS
Selection and quantification of mosaic clone size and dispersion
In ES cells transfected with Cre, the different cellular ratios were obtained by FACS or after immunostaining for the different fluores-
cent proteins (anti-GFP, anti-Dsred, anti-Kate2) or specific epitopes (V5 or HA tag). Quantification was performed with Fiji/ImageJ.
Signal tresholds were defined before quantification of the number of cells/nuclei having a specific color. In the case of mosaics of
cells expressing only membrane localized FPs, relative areas were quantified and related with cell number, after quantifying the
average cell number per area based on Hoechst staining or nuclei marker proteins.
In the neural tube of E12.5 embryos, clones were identified on 3D confocal scanning volumes (4-5 Z slices), acquired from 20mm
thick cryosections, after immunostaining for the different marker proteins (Fig. 2C and S3B). Cloneswere scored based on their nuclei
colour, number and distribution. Sections with too many clones having the same colour were not quantified. In the neural tube,
neuronal progenitors obey horizontal domains (Briscoe and Small, 2015), being easier to assign single-cell derived progeny.
In the retinas of newborn mice, a superficial network of vessels grows from P1 to P7. Retinas can be microdissected, stained and
flat-mounted with this superficial network facing the coverslip. Endothelial clones were identified on large 3D tile confocal scanning
volumes (2-4 Z slices), acquired fromwholemount fixed retinas, stained for different marker proteins. 20x or 40x objectives were used
for the tile scanning and Fiji/ImageJ to threshold, select and quantify clones. For the selection of clones in these volumes different
parameters were considered. The clone single or dual color-code, its relative intensity (which varies between clones derived from
different cells), its size and dispersion, and its proximity to other clones. To calculate the average Dual ifgMosaic clone dispersion,
relative to its size, we measured in Fiji/ImageJ, the shortest path linking the center of the identified clone nuclei (see Figure S3F). For
the accurate quantification and delimitation of the most frequent dual clones, in areas with higher frequencies of recombination, the
average clone dispersion value can be used to define areas that are very likely to contain all cells of an individual clone and no cells
from adjacent single-cell derived dual clones. The higher the signal intensity and spectral separation, the easier is the quantification
process. With the second generation ifgMosaic mice automatic signal data segmentation and quantification can be applied.
P-ERK relative signal intensity quantification
The average background level of P-ERK immunofluorescence signal was quantified in the non-vascular tissue surrounding
IsolectinB4+ ECs and assigned as zero intensity value (Fig. 3D). Individual IsolectinB4+/MbTomato+ and adjacent IsolectinB4+/
MbTomato- ECs were selected based on the anti-dsred immunofluorescent signal. Within the MbTomato- endothelial population,
tip cells were manually selected according to their position at the edge of the angiogenic front, and stalk-cells were selected as
non-tip cells adjacent to MbTomato+ cells. The average absolute pixel P-ERK signal intensity was quantified in each selected cell
area, in relation to the average non-vascular signal background level.e6 Cell 170, 800–814.e1–e7, August 10, 2017
Statistical analysis
In the case of two groups comparisons, two-tailed, Student’s T test was used. ANOVA was used for multiple groups comparison. In
the case of the nonparametric data displayed in Figure 4G, Kruskal-Wallis one-way analysis of variance was used. p values above
0,05 were considered not significant (NS). All calculations and charts were performed with GraphPad Prism software. No random-
ization or blinding was used and animals/tissues were selected for analysis based on the detected Cre-dependent recombination
frequency and quality of multiplex immunostaining. The sample size was chosen according to the observed statistical variation
and published protocols.
DATA AND SOFTWARE AVAILABILITY
The DNA sequences of the plasmids used in this study, and illustrated in Figures S2, S6, and S7, are deposited at Addgene
(#99613–99632 and #99748–99752).Cell 170, 800–814.e1–e7, August 10, 2017 e7
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Figure S1. Multiple Dual Fluorescent Reporters for Determining Gene Effects on Cell Shape, Migration, and Proliferation, Related to Figure 1
(A) Several different constructs (1-6) were assembled and tested for the simultaneous expression of Mb- and H2B-tagged marker proteins and a given gene of
interest.
(B) Immunostaining of stable cell lines expressing constructs 1-3 with three different antibodies (anti-GFP, anti-DsRed, and anti-Kate2).
(C) Live imaging (see also Movie S1) with 3 laser lines (458, 488, and 546nm) and 5 different detector settings to capture the chromatin and membrane of all cells
containing constructs 4-6 (see, a), allowing simultaneous visualization of the effect of different genes on cell division and migration in the same acquisition field.
Legend: Mb - Tag that localizes proteins to the cell membrane. 2A – 21-aminoacid viral peptide sequence cleaved at the C-terminal position, allowing equimolar
and independent localization of two flanking proteins coded in the same ORF. Au1, V5, HA, His - short epitope tags that can be detected by specific antibodies.
H2B - Histone 2B protein tag that localizes proteins to the chromatin/cell nucleus. pA - polyadenylation transcription stop signal.
(D) Brainbow 2.1 expression in endothelial cells of the mouse retina. This mouse line allows the induction after Cre recombination of up to 4 FPs (nGFP, YFP,
MbCFP, and RFP) that are excited and emit signals at different wavelengths. Confocal scanning of the endogenous protein fluorescence signals after tissue
fixation can only provide high resolution of the strongest signals. Immunostaining with antibodies to GFP greatly improves signal intensity, but detects nGFP, YFP,
and MbCFP simultaneously, compromising their proper distinction in the same tissue.
(legend on next page)
Figure S2. Inducible Membrane and Chromatin Mosaic Constructs, Cells, and Mice, Related to Figures 1–4
(A–C) Some of the iMb-Mosaic DNA constructs assembled and used to generate ES cell and mouse lines and the indicated abbreviated names.
CAG, Strong and ubiquitous promoter; PGK-Neo, resistance marker for ES cell selection; L1, LoxN; L2, Lox2272; L3, LoxP; 2A, viral peptide allowing equimolar
expression of multiple independent proteins from a single ORF; Mb, membrane tag; HA, V5 and His (small epitopes that can be used for specific antibody
detection); H2B, histone tag that targets proteins to the chromatin/nucleus; BghpA, bovine growth hormone polyadenylation signal to stop transcription; N-PhiM,
non-fluorescent protein that is used as a reporter of promoter expression. DN-Rbpj and DN-Maml1 are dominant-negative proteins that sequester the
endogenous Notch intracellular domain (NICD) and reduce Notch receptor signaling in a cell-autonomous manner. NICD Ac. or NICD-PEST is the active form of
NICD, containing the native PEST domain that results in a relatively moderate increase of ligand independent Notch activity. VEGFR2Ac. is the constitutively active
form of VEGFR2 without the extracellular domain. Vegfr2TK is a tyrosine kinase-domain mutant version of murine Vegfr2 that strongly reduces VEGF signaling in
a cell-autonomous manner.
(D) Representative confocal micrograph of a retina from amouse containing the alleles iMb-Control-Mosaic andCdh5-CreERT2, which results in amosaic of ECs
(IsolectinB4+) expressing MbYFP or MbTomato or MbKate2.
(E–G) Some of the iChr-Mosaic DNA constructs assembled and used to generate ES cell and mouse lines and the indicated abbreviated names.
(H) Representative confocal micrograph of a retina from amouse containing the alleles iChr-Control-Mosaic andCdh5-CreERT2, which results in amosaic of ECs
(IsolectinB4+), expressing H2B-Cherry, H2B-GFP-V5, or H2B-Cerulean. Cerulean is detected by the anti-GFP antibody only.
(I) For each construct is indicated the distinct inter-LoxP sites genetic distances and the detected cellular ratios in ES cells 48h (left) or 8 days (right) after
transfection with Cre-expressing plasmids. Ratios in iMb-Mosaic indicate relative surface area, whereas in iChr-Mosaic indicate relative cell number. At least two
independent Cre plasmid transfection experiments and 12 pictures representing large microscopic fields (10x lens) were used to calculate the indicated mean
values.
(J) Confocal scanning micrographs of selected areas shown in Figure 1H, showing the different fluorescence signals from an ES cell line containing both the iMb-
Control-Mosaic and iChr-Control-Mosaic alleles. The color combinations make it possible to separate multiple cell clones. The MbKate2 signal from the iMb-
Control-Mosaic allele is weak when acquired with the same confocal acquisition settings used for the stronger H2B-Cherry signal from the iChr-Control-Mosaic
allele.
(legend on next page)
Figure S3. Inducible iChr-Notch-Mosaic and iMb-Vegfr2-Mosaic, Related to Figures 2–4
(A) Schematic representation of the genetic construct used to generate the iChr-Notch-Mosaic mice.
(B) Representative pictures of iChr-Notch-Mosaic Polr2a-CreERT2 embryos with lower frequency of labelled clones in the neural tube, further supporting the data
shown in Figure 2.
(C and D) qRT-PCR analysis of RNA extracted from FACS sorted ECs from iChr-Notch-Mosaicmice. Canonical Notch signaling targets (Hey1, Hey2 and Efnb2)
change significantly in cells with loss (GFP+ in [C]) or gain (Cerulean+ in [D]) of Notch function. NS, not significant, * p<0.05 and ** p<0.001. Cdh5 and Pecam are
control endothelial genes not regulated by Notch. n=2, error bars represent Stdev.
(E) Schematic representation of the genetic construct used to generate the iMb-Vegfr2-Mosaic mice. These mice were intercrossed with Cdh5-CreERT2 mice
and the progeny injected with tamoxifen at postnatal day 3 (P3). At P6, retinas were immunostained to detect the cellular mosaic as shown.
(F) Chart showing the quantification of the average clone dispersion for each clone size. On the right a representative picture of a dual clone with 5 cells and a 256
micron cumulative distance between all nuclei. Error bars, s.e.m. This distance can be used to define areas for clone identification and quantification, in relation to
their size.
(G) Negative exponencial regression model used to derive the 1/K value, that gives an estimation of the proliferative capacity of the different cells shown in
Figure 4F. BE cells are the most proliferative and the BF the least proliferative.
(legend on next page)
Figure S4. Overcoming Limitations of Classical Gene Targeting through the Generation of Rosa26 ifgMosaic BACs, Related to Figure 5
(A) Map of a typicalRosa26 gene-targeting vector containing 28.5kb of DNA encoding all the elements required for preciseRosa26 gene targeting and strong Cre-
dependent induction of a fluorescent-genetic mosaic. These vectors are very difficult to assemble due to their large size and multiple repetitive elements.
(B) Comparison of the time required to generate an ifgMosaic mouse line by classical gene targeting versus the new Rosa26 ifgMosaic BAC method.
(C) Three step method for the engineering of Rosa26 ifgMosaic BACs.
(D) Plasmids and BACs used at the different steps to generate the final Rosa26 ifgMosaic BAC. Restriction analysis gel pictures indicate the successful engi-
neering of the DNA constructs at the different steps.
Figure S5. Rosa26 ifgMosaic BACs, Related to Figure 5
(A–C) Maps of selected Rosa26 ifgMosaic BACs generated by DNA recombineering. These BACs contain the CAG (A), UAS 4x NR (B), or Tre-Tight (C) promoters.
(legend on next page)
Figure S6. iMb2- and iChr2-Mosaic Recombination Frequencies and Signals, Related to Figure 7
(A) Diagrams showing the genetic distances between the LoxP sites in the DNA constructs used to produce the different ifg2Mosaicmice. Genetic distance is not
the only factor that influences the relative ratios of recombination. The frequencies (%) indicated above the FACS plots were obtained in ES cells transfected with
Cre-expressing plasmids and analysed by FACS, and later confirmed also by immunostaining. The frequencies below were obtained by confocal microscopy of
ECs from ifg2Mosaic Cdh5-CreERT2+mice, pulsed once with tamoxifen. The differences observed in the recombination ratios are caused by the higher levels of
Cre activity obtained in ES cells than in ECs expressing CreERT2 and pulsed only once with tamoxifen.
(B) Confocal micrograph showing the 4 signals detected after immunostaining with the indicated antibodies, of the postnatal mouse retina of Dual ifg2Mosaic
mice, carrying the Cdh5-CreERT2 allele, and pulsed once with tamoxifen.
(C) Endogenous fluorescence detection in endothelial cells of the same mice after retina tissue fixation, and labeling with conjugated IsolectinB4-647. A total of
7 fluorescent signals (6 endogenous and 1 immunolabeled), excited with the indicated laser lines, could be detected with high resolution and in a large acquisition
field. Magnified boxed areas and two-letter codes show selected double-recombined cell clones and the observed combination of FPs A to F, at higher
magnification. Pictures further below show the different signals separately.
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Figure S7. List of All DNA Constructs Used to Produce the Different Second-Generation ifgMosaic Constructs, Related to Figures 5–7
(A and B) LoxP- (A) or FRT-containing (B) entry vectors used to clone the desired genes in frame with the upstream FPs and the 2A peptide.
(C and D) Map of LoxP- (C) or FRT-containing (D) donor vector used to clone the 3 cassettes from (A) or (B) in the HindIII/NotI sites.
(E and F) The Triple ORF donor vectors of C and D can be digested with SgraI/PacI or SgraI/ScaI to insert the mosaic by Cas9 recombineering in pre-modified ES
cells (E) or by ligation to Rosa26 gene targeting vectors (F). Plasmids LH500 or LH416 are required to express and guide the Cas9 to the pre-modified (E) or
wildtype (F) Rosa26 locus.
(G) The large SgraI/PacI fragments generated in C and D can be inserted by recombineering in different acceptor Rosa26 BACs containing the following pro-
moters: CAG, Tre-Tight, or UAS 4x NR (4 UAS elements non-repeated). BAC G256 can be used for transgenesis in zebrafish and contains a marker to directly
select transgenic founders (Cmcl2-turquoise) based on turquoise fluorescence in the heart.
(H) Smaller vectors that can be used to directly clone themosaic constructs downstream of the Tre-Tight or UAS promoters for titratable and reversible induction.
These vectors can also be digested with the rare cutters SgraI/PacI and cloned in a plasmid (AG103) containing the Rosa26 homology arms for gene targeting.
LOXP1,LoxN; LOXP2,Lox2272; LOXP3,LoxP; FRT1,F3; FRT2,5T2; FRT3,545; 2A, viralpeptideallowingequimolarexpressionofmultiple independentproteins from
a single ORF;Mb2, second generationmembrane tag; HA, V5 andHis (small epitopes that can be used for specific antibody detection); H2B, histone tag that targets
proteins to the chromatin/nucleus; WPRE, Woodchuck Hepatitis Virus Posttranscriptional Regulatory Element that enhances gene expression; Sv40pA, poly-
adenylation signal to stop transcription; N-PhiM, non-fluorescent protein that is used as a reporter of promoter expression; CAG, Strong and ubiquitous promoter;
PGK-Neo, resistance marker for ES cell selection; INS-INS, Double Chicken B-globin insulator to increase gene expression and minimize regulatory interference.
